pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Pulmonology · news · pharmadog
← back to Pulmonology
News · Pulmonology
512
stories
20d
Pennsylvania records third measles-related death amid outbreak
stat
20d
STAT+: Definium’s LSD therapy eased anxiety in second large trial
stat
20d
The GOP’s $50 billion rural health fund is coming up short, hospital leaders say
stat
20d
Roche, MediLink notch phase 3 lung cancer win but trail GSK on cross-trial survival
fiercebiotech
20d
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
biospace
20d
After a brief storm of political headwinds, mRNA is back with strong momentum
biospace
23d
STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle loss
stat
23d
Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer
fiercebiotech
23d
STAT+: Cancer drug shortages keep disrupting patient care
stat
23d
Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use
biopharma dive
23d
Frazier adds $1.1B+ to small and mid-sized biotech fund
biospace
23d
BioNTech sets survival standard in hard-to-treat cancer ahead of pivotal readout
fiercebiotech
23d
Opinion: I’m a thoracic surgeon in New York City. For many of my patients, Sept. 11 is still not over
stat
23d
STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field
stat
23d
GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck
fiercebiotech
24d
STAT+: Right before midterms, Trump dangles $500 refunds for select ACA enrollees
stat
24d
Platinum-based chemotherapy in childhood causes mutations that age the liver
stat
24d
Andy Plump, architect of Takeda’s R&D overhaul, to retire next year
biopharma dive
24d
Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label
endpoints
24d
STAT+: Can AI save rural health care?
stat
24d
STAT+: FDA expands Bayer lung cancer drug approval
stat
24d
Drugmakers cherry pick launch regions as MFN creates 'policy environment like an earthquake'
biospace
24d
STAT+: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon
stat
24d
August biopharma layoffs impact just over 500, down 90% year over year
biospace
25d
STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more
stat
25d
Telemedicine company offers GLP-1s for addiction
stat
25d
A new immuno-oncology play raises $225M for a next-generation drug
biopharma dive
25d
STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea
stat
26d
STAT+: FDA names acting heads of drug and vaccine centers to permanent roles
stat
26d
Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy
biopharma dive
← prev
page 4 of 18
next →
